Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies

P Sharma, P Srivastava, A Seth, PN Tripathi… - Progress in …, 2019 - Elsevier
AD is a progressive neurodegenerative disorder and a leading cause of dementia in an
aging population worldwide. The enormous challenge which AD possesses to global …

Advances in targeting cyclic nucleotide phosphodiesterases

DH Maurice, H Ke, F Ahmad, Y Wang… - Nature reviews Drug …, 2014 - nature.com
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and
cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides …

Rational multitargeted drug design strategy from the perspective of a medicinal chemist

X Li, X Li, F Liu, S Li, D Shi - Journal of Medicinal Chemistry, 2021 - ACS Publications
The development of multitarget-directed ligands (MTDLs) has become a widely focused
research topic, but rational design remains as an enormous challenge. This paper reviews …

Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions

SH Francis, MA Blount, JD Corbin - Physiological reviews, 2011 - journals.physiology.org
The superfamily of cyclic nucleotide (cN) phosphodiesterases (PDEs) is comprised of 11
families of enzymes. PDEs break down cAMP and/or cGMP and are major determinants of …

[HTML][HTML] Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitors

WS Ahmed, AM Geethakumari, KH Biswas - Biomedicine & …, 2021 - Elsevier
Abstract Phosphodiesterase 5 (PDE5) is one of the most well-studied phosphodiesterases
(PDEs) that specifically targets cGMP typically generated by nitric oxide (NO)-mediated …

Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling

M Conti, J Beavo - Annu. Rev. Biochem., 2007 - annualreviews.org
Although cyclic nucleotide phosphodiesterases (PDEs) were described soon after the
discovery of cAMP, their complexity and functions in signaling is only recently beginning to …

Intramolecular hydrogen bonding in medicinal chemistry

B Kuhn, P Mohr, M Stahl - Journal of medicinal chemistry, 2010 - ACS Publications
The formation of intramolecular hydrogen bonds has a very pronounced effect on molecular
structure and properties. We study both aspects in detail with the aim of enabling a more …

Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders

S Delhaye, B Bardoni - Molecular Psychiatry, 2021 - nature.com
Phosphodiesterases (PDEs) are enzymes involved in the homeostasis of both cAMP and
cGMP. They are members of a family of proteins that includes 11 subfamilies with different …

Keynote review: phosphodiesterase-4 as a therapeutic target

MD Houslay, P Schafer, KYJ Zhang - Drug discovery today, 2005 - Elsevier
Cyclic AMP (cAMP) is a key second messenger in all cells. It is compartmentalized within
cells and its levels are controlled, as a result of spatially discrete signaling cassettes …

Cyclic diguanylate is a ubiquitous signaling molecule in bacteria: insights into biochemistry of the GGDEF protein domain

DA Ryjenkov, M Tarutina, OV Moskvin… - Journal of …, 2005 - Am Soc Microbiol
Proteins containing GGDEF domains are encoded in the majority of sequenced bacterial
genomes. In several species, these proteins have been implicated in biosynthesis of …